{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:25:52Z","timestamp":1787109952214,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":4309,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.anpedi.2014.06.015","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T23:00:22Z","timestamp":1406242822000},"page":"329.e1-329.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vacunas multivalentes frente a enfermedad meningoc\u00f3cica: \u00bfdentro o fuera de nuestras agendas?"],"prefix":"10.1016","volume":"81","author":[{"given":"R.","family":"Abad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2014.06.015_bib0005","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1517\/14712598.2013.812629","article-title":"Quadrivalent meningococcal serogroups A, C W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT): A review","volume":"13","author":"Ghanem","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0010","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1016\/j.vaccine.2013.07.083","article-title":"Effectiveness of meningococcal serogroup C vaccine programmes","volume":"31","author":"Borrow","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2807\/esm.02.10.00146-en","article-title":"Changing epidemiology of meningococcal disease in Spain, 1989-1997","volume":"2","author":"Mateo","year":"1997","journal-title":"Euro Surveil"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0020","first-page":"261","article-title":"Vaccination programme for group C meningococcal infection is launched","volume":"9","year":"1999","journal-title":"Commun Dis Rep CDR Wkly"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0025","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.vaccine.2014.03.010","article-title":"Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification","volume":"32","author":"Garrido-Estepa","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0030","unstructured":"Revisi\u00f3n del programa de vacunaci\u00f3n frente a enfermedad meningoc\u00f3cica por serogrupo. [consultado 20 May 2014]. Disponibl en: http:\/\/www.msssi.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/MenC.pdf"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0035","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-14-280","article-title":"Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain)","volume":"14","author":"P\u00e9rez-Breva","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.anpedi.2014.06.015_bib0040","doi-asserted-by":"crossref","first-page":"B26","DOI":"10.1016\/j.vaccine.2011.12.032","article-title":"The changing and dynamic epidemiology of meningococcal disease","volume":"30","author":"Halperin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0045","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1097\/INF.0b013e318279ac38","article-title":"Antibody persistence and response to a booster dose of a quadrivalent conjugate vaccine for meningococcal disease in adolescents","volume":"32","author":"Jacobson","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0050","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.2165\/11209580-000000000-00000","article-title":"Meningococcal quadrivalent (serogroups A, C W135 and Y) tetanus toxoid conjugate vaccine (Nimenrix\u2122)","volume":"72","author":"Croxtall","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40265-013-0155-7","article-title":"A multi-component meningococcal serogroup b vaccine (4CMenB): The Clinical Development Program","volume":"74","author":"O\u2019Ryan","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0060","doi-asserted-by":"crossref","first-page":"e35699","DOI":"10.1371\/journal.pone.0035699","article-title":"Whole genome sequencing to investigate the emergence of clonal complex 23 Neisseria meningitidis serogroup Y disease in the United States","volume":"7","author":"Krauland","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0065","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1128\/JCM.02134-06","article-title":"Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada","volume":"45","author":"Tsang","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"RR02","key":"10.1016\/j.anpedi.2014.06.015_bib0070","first-page":"1","article-title":"Prevention and control of meningococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0075","unstructured":"Centers for Disease Control and Prevention. Active bacterial core surveillance report, Emerging Infections Program Network, Neisseria meningitidis, 2011. Centers for Disease Control and Prevention [consultado 21 Jun 2013]. Disponible en: http:\/\/www.cdc.gov\/abcs\/reportsfindings\/survreports\/mening11.pdf"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0080","unstructured":"Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 2004. Centers for Disease Control and Prevention [consultado 21 Jun 2013]. Disponible en: http:\/\/www.cdc.gov\/abcs\/reportsfindings\/survreports\/mening04.pdf"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0085","first-page":"184","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: Implications for prevention of meningococcal disease","volume":"210","author":"Cohn","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0090","first-page":"997","article-title":"National, state, and local area vaccination coverage among adolescents aged 13-17 years \u2014United States, 2008","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0095","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.4161\/hv.24009","article-title":"Response to the changing epidemiology of meningococcal disease in North America 1945-2010","volume":"9","author":"Bettinger","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0100","unstructured":"Public Health Agency of Canada. Invasive meningococcal disease (IMD) [consultado 30 Ene 2014]. Disponible en: http:\/\/www.phac-aspc.gc.ca\/im\/vpd-mev\/meningococcal-eng.ph"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jinf.2009.06.001","article-title":"Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America region","volume":"59","author":"Abad","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0110","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3201\/eid1703.101254","article-title":"Surveillance for invasive meningococcal disease in children US-Mexico border, 2005-2008","volume":"17","author":"Chacon-Cruz","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0115","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.4161\/hv.21794","article-title":"Meningococcal serogroup Y emergence in Europe: Update 2011","volume":"8","author":"Br\u00f6ker","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0120","article-title":"Genetic characterisation of the emerging invasive Neisseria meningitidis serogroup Y in Sweden, 2000 to 2010","volume":"16","author":"Hedberg","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/hv.28206","article-title":"Meningococcal serogroup Y emergence in Europe: High importance in some European regions in 2012","volume":"10","author":"Br\u00f6ker","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0130","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1086\/340414","article-title":"Outbreak of W135 meningococcal disease in 2000: Not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex","volume":"185","author":"Mayer","year":"2002","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.anpedi.2014.06.015_bib0135","doi-asserted-by":"crossref","first-page":"A37","DOI":"10.1016\/j.vaccine.2007.04.038","article-title":"The first large epidemic of meningococcal disease caused by serogroup W135 Burkina Faso, 2002","volume":"25","author":"Koumar\u00e9","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1073\/pnas.94.1.271","article-title":"Capsule switching of Neisseria meningitidis","volume":"94","author":"Swartley","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0145","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0463.2005.apm1130305.x","article-title":"Pharyngeal carriage of serogroup W135 Neisseria meningitidis in Hajjees and their family contacts in Morocco, Oman and Sudan","volume":"113","author":"Nicolas","year":"2005","journal-title":"APMIS"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0150","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4067\/S0716-10182012000700001","article-title":"Enfermedad meningoc\u00f3ccica: siempre presente. Cambios en los serogrupos en el Cono Sur","volume":"29","author":"L\u00f3pez","year":"2012","journal-title":"Rev Chilena Infectol"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0155","doi-asserted-by":"crossref","first-page":"e44102","DOI":"10.1371\/journal.pone.0044102","article-title":"Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010","volume":"7","author":"Ibarz-Pav\u00f3n","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.anpedi.2014.06.015_bib0160","unstructured":"Ministerio Salud P\u00fablica Republica de Chile. Enfermedad Meningoc\u00f3cica (CIE 10: A39). Situaci\u00f3n epidemiol\u00f3gica, enero-diciembre, 2013. Plan Acci\u00f3n W-135 [consultado 22 Ene 2014]. Disponible en: http:\/\/epi.minsal.cl\/epi\/html\/AtlasInteractivos\/AtlasBET\/ABET_04\/EM_BET4.pdf"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0165","first-page":"350","article-title":"Clinical characterization of cases with meningococcal disease by W135 group in Chile, 2012","volume":"30","author":"Moreno","year":"2013","journal-title":"Rev Chilena Infectol"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0170","first-page":"354","article-title":"Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine","volume":"13","author":"Kristiansen","year":"2013","journal-title":"BioMed Central Infectious Diseases"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0175","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4161\/hv.19619","article-title":"Development of a group A meningococcal conjugate vaccine. MenAfriVac(TM)","volume":"8","author":"Frasch","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/cit222","article-title":"Lack of association of Guillain-Barr\u00e9 syndrome with vaccinations","volume":"57","author":"Baxter","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0185","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s40265-013-0079-2","article-title":"Meningococcal vaccines: Current issues and future strategies","volume":"73","author":"Cohn","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0190","unstructured":"Vesikari T, Forsten A, van der Wielen M, Bianco V, Miller JM. 12th EMGM meeting, Austria, 2013 [consultado 11 Jun 2014]. Disponible en: http:\/\/emgm.eu\/meetings\/emgm2013\/Abstract_Book_EMGM_2013.pdf"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0195","unstructured":"Grupo de Trabajo MenB. Vacuna frente a enfermedad meningoc\u00f3cica invasora por serogrupo B y su posible utilizaci\u00f3n en salud p\u00fablica. Ponencia de Programas y Registro de Vacunaciones. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad, 2013[consultado 22 Ene 2014]. Disponible en: http:\/\/www.msssi.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/MenB.pdf"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0200","unstructured":"European Centre for Disease Prevention and Control (ECDC). Vaccine Schedule [consultado 22 Ene 2014]. Disponible en: http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0205","first-page":"39","article-title":"Update on the use of quadrivalent conjugate meningococcal vaccines","year":"2013","journal-title":"Canada Communicable Disease Report CCDR."},{"key":"10.1016\/j.anpedi.2014.06.015_bib0210","unstructured":"Ministry of Health Portal. Kingdom of Saudi Arabia. Basic Vaccination Schedule [consultado 26 Jul 2013]. Disponible en: http:\/\/www.moh.gov.sa\/en\/HealthAwareness\/EducationalContent\/HealthTips\/Pages\/Tips-005.aspx"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0215","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3201\/eid1709.101762","article-title":"Carriage of meningococci by university students, United Kingdom","volume":"17","author":"Ala\u2019aldeen","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.anpedi.2014.06.015_bib0220","unstructured":"Abad R, Bellisco S, Fari\u00f1as MC, Garc\u00eda S, Martinez-Martinez L, Medina V, et al. Meningococcal carriers survey in a high endemic region in Spain. XVIIIth International Pathogenic Neisseria Conference (IPNC) [consultado 22 Ene 2014]. Disponible en: http:\/\/neisseria.org\/ipnc\/2012\/IPNC_2012_abstracts.pdf"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403314003300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403314003300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:40:15Z","timestamp":1787107215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403314003300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1695403314003300"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2014.06.015","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vacunas multivalentes frente a enfermedad meningoc\u00f3cica: \u00bfdentro o fuera de nuestras agendas?","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2014.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}